Hereditary Metabolic Bone Diseases: A Review of Pathogenesis, Diagnosis and Management

被引:28
作者
Charoenngam, Nipith [1 ,2 ,3 ]
Nasr, Aryan [1 ]
Shirvani, Arash [1 ]
Holick, Michael F. [1 ]
机构
[1] Boston Univ, Dept Med, Sect Endocrinol Nutr & Weight Management, Sch Med, Boston, MA 02118 USA
[2] Harvard Med Sch, Mt Auburn Hosp, Dept Med, Cambridge, MA 02138 USA
[3] Mahidol Univ, Fac Med, Dept Med, Siriraj Hosp, Bangkok 10700, Thailand
关键词
metabolic bone disease; sclerosing disorders; osteopetrosis; hypophosphatemic rickets; vitamin D-dependent rickets; hypophosphatasia; achondroplasia; osteogenesis imperfecta; hereditary connective tissue disorder; CAMURATI-ENGELMANN-DISEASE; EHLERS-DANLOS-SYNDROME; PRIMARY HYPERTROPHIC OSTEOARTHROPATHY; OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; ENZYME-REPLACEMENT THERAPY; PAGETS-DISEASE; OSTEOGENESIS IMPERFECTA; OSTEOPATHIA STRIATA; CRANIAL SCLEROSIS; MINERAL DENSITY;
D O I
10.3390/genes13101880
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hereditary metabolic bone diseases are characterized by genetic abnormalities in skeletal homeostasis and encompass one of the most diverse groups among rare diseases. In this review, we examine 25 selected hereditary metabolic bone diseases and recognized genetic variations of 78 genes that represent each of the three groups, including sclerosing bone disorders, disorders of defective bone mineralization and disorder of bone matrix and cartilage formation. We also review pathophysiology, manifestation and treatment for each disease. Advances in molecular genetics and basic sciences has led to accurate genetic diagnosis and novel effective therapeutic strategies for some diseases. For other diseases, the genetic basis and pathophysiology remain unclear. Further researches are therefore crucial to innovate ways to overcome diagnostic challenges and develop effective treatment options for these orphan diseases.
引用
收藏
页数:34
相关论文
共 212 条
[1]   Camurati-Engelmann Disease with Good Treatment Response to Losartan [J].
Abdulla, Mansoor Chertimkuhiyil .
INDIAN JOURNAL OF NUCLEAR MEDICINE, 2019, 34 (03) :223-225
[2]  
Abdullah NRA, 2017, ENDOCRINOL DIAB META, DOI 10.1530/EDM-17-0029
[3]   Losartan as a Steroid-Sparing Adjunct in a Patient With Features of Refractory Camurati-Engelmann Disease [J].
Agarwal, Khushboo ;
Rajan, Remya ;
Paul, Jinson ;
Cherian, Kripa Elizabeth ;
Kapoor, Nitin ;
Paul, Thomas, V .
AACE CLINICAL CASE REPORTS, 2022, 8 (02) :54-57
[4]   Clinical and molecular findings in osteoporosis-pseudoglioma syndrome [J].
Ai, MR ;
Heeger, S ;
Bartels, CF ;
Schelling, DK .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (05) :741-753
[5]  
Akaranuchat Nutthawut, 2019, JPRAS Open, V21, P6, DOI 10.1016/j.jpra.2019.04.004
[6]   Targeting TGF-β Signaling for Therapeutic Gain [J].
Akhurst, Rosemary J. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2017, 9 (10)
[7]   Clinical and Genetic Advances in Paget’s Disease of Bone: a Review [J].
Alonso N. ;
Calero-Paniagua I. ;
del Pino-Montes J. .
Clinical Reviews in Bone and Mineral Metabolism, 2017, 15 (1) :37-48
[8]  
[Anonymous], 2002, NEW ENGL J MED, V347, P1622, DOI [10.1056/NEJM200211143472015, DOI 10.1056/NEJM200211143472015]
[9]   Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) [J].
Balemans, W ;
Ebeling, M ;
Patel, N ;
Van Hul, E ;
Olson, P ;
Dioszegi, M ;
Lacza, C ;
Wuyts, W ;
Van den Ende, J ;
Willems, P ;
Paes-Alves, AF ;
Hill, S ;
Bueno, M ;
Ramos, FJ ;
Tacconi, P ;
Dikkers, FG ;
Stratakis, C ;
Lindpaintner, K ;
Vickery, B ;
Foernzler, D ;
Van Hul, W .
HUMAN MOLECULAR GENETICS, 2001, 10 (05) :537-543
[10]   LONG-TERM NOCTURNAL CALCIUM INFUSIONS CAN CURE RICKETS AND PROMOTE NORMAL MINERALIZATION IN HEREDITARY RESISTANCE TO 1,25-DIHYDROXYVITAMIN-D [J].
BALSAN, S ;
GARABEDIAN, M ;
LARCHET, M ;
GORSKI, AM ;
COURNOT, G ;
TAU, C ;
BOURDEAU, A ;
SILVE, C ;
RICOUR, C .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (05) :1661-1667